MMSI

Handel nachbörslich: 105.71

Merit Medical Systems Inc (MMSI)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Merit Medical Systems Inc Stock (MMSI) Company Profile

Merit Medical Systems Inc

Healthcare (1164)

(801) 253-1600

1600 WEST MERIT PARK WAY, SOUTH JORDAN, UT

@meritmedical

Nächster Verdiensttermin

Neueste SEC-Einreichungen

MMSI's Discussions on Twitter

Vergleichen Sie MMSI mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
MMSI Merit Medical Systems Inc	105.71	6.00B	1.33B	120.04M	172.71M	2.05
ISRG Intuitive Surgical Inc	495.27	181.97B	8.35B	2.32B	1.30B	6.41
BDX Becton Dickinson Co	229.06	66.11B	20.64B	1.73B	2.94B	6.02
ALC Alcon Inc	94.93	46.83B	9.91B	1.02B	665.00M	2.05
RMD Resmed Inc	223.85	32.94B	4.93B	1.25B	1.38B	8.47
BAX Baxter International Inc	34.23	17.65B	17.28B	108.00M	391.00M	0.20

Merit Medical Systems Inc Stock (MMSI) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-03-28	Eingeleitet	JP Morgan	Overweight
2024-12-11	Hochstufung	Wells Fargo	Equal Weight → Overweight
2024-06-28	Eingeleitet	Robert W. Baird	Outperform
2024-04-11	Eingeleitet	CL King	Buy
2024-02-07	Eingeleitet	BofA Securities	Neutral
2023-12-21	Hochstufung	Canaccord Genuity	Hold → Buy
2022-12-20	Herabstufung	Canaccord Genuity	Buy → Hold
2021-01-05	Hochstufung	Needham	Hold → Buy
2020-09-28	Hochstufung	Wells Fargo	Underweight → Equal Weight
2020-02-25	Herabstufung	Barrington Research	Outperform → Mkt Perform
2020-02-03	Hochstufung	Raymond James	Mkt Perform → Outperform
2019-12-12	Herabstufung	Wells Fargo	Market Perform → Underperform
2019-09-24	Eingeleitet	Oppenheimer	Outperform
2019-09-10	Herabstufung	Raymond James	Outperform → Mkt Perform
2019-07-26	Herabstufung	Needham	Buy → Hold
2019-07-26	Herabstufung	Wells Fargo	Outperform → Market Perform
2018-10-02	Bestätigt	Needham	Buy
2018-08-07	Herabstufung	BofA/Merrill	Buy → Underperform
2018-07-24	Bestätigt	Needham	Buy
2018-06-01	Bestätigt	Needham	Buy
2018-05-18	Bestätigt	SunTrust	Buy
2018-04-26	Bestätigt	Needham	Buy
2018-04-20	Eingeleitet	Needham	Buy
2018-03-01	Hochstufung	Barrington Research	Mkt Perform → Outperform
2017-08-28	Herabstufung	Raymond James	Strong Buy → Outperform
2017-07-20	Eingeleitet	BofA/Merrill	Buy
2017-06-20	Eingeleitet	SunTrust	Buy
2017-04-05	Eingeleitet	Wells Fargo	Outperform

Alle ansehen

Merit Medical Systems Inc Aktie (MMSI) Neueste Nachrichten

Finanzdaten der Merit Medical Systems Inc-Aktie (MMSI)

Merit Medical Systems Inc (MMSI)

Merit Medical Systems Inc Stock (MMSI) Company Profile

Vergleichen Sie MMSI mit anderen Aktien

Merit Medical Systems Inc Stock (MMSI) Upgrades & Downgrades

Merit Medical Systems Inc Aktie (MMSI) Neueste Nachrichten

Is Now An Opportune Moment To Examine Merit Medical Systems, Inc. (NASDAQ:MMSI)? - simplywall.st

JPMorgan starts Merit Medical with Overweight, $120 target By Investing.com - Investing.com Australia

This Merit Medical Systems Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga

Assessing Merit Medical Systems: Insights From 12 Financial Analysts - Benzinga

JPMorgan Initiates Merit Medical Systems at Overweight With $120 Price Target - MarketScreener

JPMorgan starts Merit Medical with Overweight, $120 target - Investing.com India

Updated ASGE Clinical Practice Guideline Includes TIF 2.0 and cTIF for Management of GERD - The Manila Times

Major Breakthrough: Merit Medical's GERD Solution Achieves 94% Success in New Guidelines - Stock Titan

Merit Medical Stock May Rise as WRAPSODY CIE Shows Strong Results - Zacks Investment Research

Advancements In Peripheral Support Catheters Driving The Market: Key Trend Transforming the Transradial Acc... - WhaTech

Merit Medical Announces 12-Month Efficacy Results For WRAPSODY CIE In Hemodialysis Patients - Nasdaq

Merit Medical Releases 12-Month Efficacy Results of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE) - The Manila Times

Merit Medical Systems Reports Promising Six-Month and Twelve-Month Results for WRAPSODY CIE in WAVE Trial - Nasdaq

Merit Medical's WRAPSODY Achieves 70% Success Rate vs 41% Standard Treatment - Stock Titan

Medical Devices & SuppliesCardiology, Neurology, Vascular Stocks Q4 Earnings: ICU Medical (NASDAQ:ICUI) Best of the Bunch - Yahoo Finance

(MMSI) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Biopsy Devices Market Generated Opportunities, Future Scope - openPR

Prostatic Artery Embolization Market Is Booming Worldwide - openPR

Merit Medical Systems, Inc. Rings the Opening Bell - Nasdaq

Merit Medical Systems, Inc. Rings the Nasdaq Stock Market Opening Bell - Nasdaq

Merit Medical Rings Nasdaq Opening Bell to Celebrate 35-Year Partnership - The Manila Times

U.S. Uterine Fibroid Treatment Market Future Business - openPR

Major Trend In The Procedure Trays Global Market 2025-2034: Innovative Solutions For Patient Safety Merit M... - WhaTech

Gastrointestinal Stent Market Booms with 6.0% CAGR Growth | TOP - openPR

Merit Medical: A Success Story That Keeps Getting Better - Seeking Alpha

MMSI Announces Commencement of Patient Enrollment in PREEMIE Study - Yahoo Finance

Interventional Neuroradiology Market Expansion: From $1.9B - openPR

Charles Schwab Investment Management Inc. Boosts Holdings in Merit Medical Systems, Inc. (NASDAQ:MMSI) - Defense World

Operating Procedure Trays Market: Key Drivers and Market - openPR

Merit Medical enrols first subject in trial of Bloom Micro Occluder System - Yahoo Finance

First patient enrolled in Merit Medical occluder system study - Mass Device

First Patient Enrolled in Merit Medical's PREEMIE Study - The Manila Times

Merit Medical Begins Clinical Trial for Groundbreaking Premature Baby Heart Treatment - StockTitan

Merit Medical Systems, Inc. to Host Earnings Call - ACCESS Newswire

Insider Selling: Merit Medical Systems, Inc. (NASDAQ:MMSI) CEO Sells $3,252,895.20 in Stock - Defense World

Insider Selling: Merit Medical Systems, Inc. (NASDAQ:MMSI) Insider Sells $3,087,000.00 in Stock - Defense World

Merit Medical Systems, Inc. (NASDAQ:MMSI) Shares Purchased by Edgestream Partners L.P. - MarketBeat

Hedge Fund and Insider Trading News: Steven Cohen, Christer Gardell, Boaz Weinstein, Rokos Capital Management, Silver Point Capital, Starboard Value, Graham Capital Management, Triata Capital, Walker & Dunlop Inc (WD), Merit Medical Systems Inc (M - Insider Monkey

Insider Selling: FRED LAMPROPOULOS Unloads $3.56M Of Merit Medical Systems Stock - Benzinga

Strategic Sale: Brian G Lloyd Decides To Exercise Options Worth $1.37M At Merit Medical Systems - Benzinga

Merit Medical Systems CEO Fred Lampropoulos sells $3.56 million in stock - Investing.com Australia

Merit Medical Systems CEO Fred Lampropoulos sells $3.56 million in stock By Investing.com - Investing.com South Africa

Merit Medical Systems’ chief legal officer sells $3.09m in stock - Investing.com Australia

Insider Sell: Brian Lloyd Sells 30,000 Shares of Merit Medical S - GuruFocus.com

Merit Medical Systems CFO Raul Jr. sells shares worth $555,292 By Investing.com - Investing.com South Africa

Merit Medical Systems’ chief legal officer sells $3.09m in stock By Investing.com - Investing.com South Africa

Merit Medical Systems CFO Raul Jr. sells shares worth $555,292 - Investing.com

Blood Pressure Monitor Market Growth USD 4.36 Billion by 2035 at a 6.1% of CAGR | Future Market Insights, Inc. - GlobeNewswire Inc.

Merit Medical’s COO Neil Peterson sells $525,000 in stock By Investing.com - Investing.com Australia

Insider Sell: Stephen Evans Sells 5,000 Shares of Merit Medical Systems Inc (MMSI) - GuruFocus.com

Finanzdaten der Merit Medical Systems Inc-Aktie (MMSI)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie MMSI